Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03179969
Other study ID # PLUG Registry
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2017
Est. completion date May 25, 2022

Study information

Verified date May 2022
Source Stiftung Institut fuer Herzinfarktforschung
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In approximately 10-15% of all patients after surgical or interventional heart valve replacement, flapping defects appear as complications in the long-term course, so-called paravalvular / paraprothetic leaks (PVL). In some patients, due to the severity of the defect, a new procedure is required - with a not inconsiderable disease or even mortality risk


Description:

In approximately 10-15% of all patients after surgical or interventional heart valve replacement, flapping defects appear as complications in the long-term course, so-called paravalvular / paraprothetic leaks (PVL). In some patients, due to the severity of the defect, a new procedure is required - with a not inconsiderable disease or even mortality risk. For a number of years, the catheter-based closure of the defect has been increasingly used by means of the implantation of plug-devices as a new treatment method for patients with a high surgical risk. The existing data on the operation method and safety of the method already used at some centers are promising. In order to demonstrate the clinical routine of patients with an interventional occlusion of a PVL in a timely manner, the Stiftung IHF Ludwigshafen will publish a multicentric register entitled "Deutsches Plug Register" The goal is, among other things, the documentation of patient characteristics, indications, and complications of treated patients.The German Heart Foundation promotes the setting up of the plug register. In this time, 200 patients with valve prosthesis defects, with which the indication for plug implantation was placed prospectively and retrospectively, are to be included in the register.


Recruitment information / eligibility

Status Completed
Enrollment 49
Est. completion date May 25, 2022
Est. primary completion date June 30, 2020
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - heart valve replacement - Valve Replacement Leaks - Plug Device Exclusion Criteria: - no written consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
paravalvular leak
Observational study on patients with paravalvular leak

Locations

Country Name City State
Germany Klinikum Ludwigshafen Ludwigshafen Deutschland

Sponsors (1)

Lead Sponsor Collaborator
Stiftung Institut fuer Herzinfarktforschung

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary mortality risk observation of the mortality risk five years
See also
  Status Clinical Trial Phase
Completed NCT00905177 - Predictors of Anticoagulation Control on Warfarin Therapy N/A
Unknown status NCT00484640 - Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing N/A
Recruiting NCT06323317 - A Prehabilitation Program for Frail Patients Undergoing Cardiac Surgeries/Procedures N/A